Clorox (NYSE:CLX) Full Year 2024 Results
Key Financial Results
- Revenue: US$7.09b (down 4.0% from FY 2023).
- Net income: US$280.0m (up 88% from FY 2023).
- Profit margin: 3.9% (up from 2.0% in FY 2023).
- EPS: US$2.26 (up from US$1.21 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Clorox EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 23%.
The primary driver behind last 12 months revenue was the Health and Wellness segment contributing a total revenue of US$2.49b (35% of total revenue). Notably, cost of sales worth US$4.05b amounted to 57% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$1.17b (42% of total expenses). Explore how CLX's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Household Products industry in the US.
Performance of the American Household Products industry.
The company's shares are up 6.6% from a week ago.
Risk Analysis
It is worth noting though that we have found 3 warning signs for Clorox (1 is potentially serious!) that you need to take into consideration.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:CLX
Clorox
Engages in the manufacture and marketing of consumer and professional products worldwide.
Reasonable growth potential with acceptable track record.
